Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Tirofiban Hydrochloride

    Client Email Product

    Tirofiban Hydrochloride

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    13
    US DMFs Filed

    US DMFs Filed

    3
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    1
    Other Suppliers

    Other Suppliers

    10
    API REF. PRICE (USD / KG)
    163,795

    API Market Place

    0

    INTERMEDIATES
    2
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    10
    Europe

    Europe

    2
    Canada

    Canada

    1
    Australia

    Australia

    2
    South Africa

    South Africa

    3
    Uploaded Dossiers

    Uploaded Dossiers

    5
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    3
    EXCIPIENTS
    4
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    13
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    15
    SERVICES

    0

    left grey arrow
    right gray arrow
    • SOLUTION;INJECTION - EQ 3.75MG BASE/15ML (EQ 0.25MG BASE/ML)
    • SOLUTION;INTRAVENOUS - EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML)
    • SOLUTION;INTRAVENOUS - EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML)
    Full View ScreenFull Screen View
    Eugia Pharma Generic Tirofiban Hydrochloride Receives Approval in the U.S
    Eugia Pharma Generic Tirofiban Hydrochloride Receives Approval in the U.S

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216379

    FDA
    01 May 2023
    Share Share
    Medicure Announces that the Shortened AGGRASTAT® Versus INTEGRILIN®
    Medicure Announces that the Shortened AGGRASTAT® Versus INTEGRILIN®

    https://www.prnewswire.com/news-releases/medicure-announces-that-the-shortened-aggrastat-versus-integrilin-in-percutaneous-coronary-intervention-savi-pci-study-has-met-its-primary-endpoint-301416972.html

    PRNEWSWIRE
    04 Nov 2021
    Share Share
    MEDICURE ANNOUNCES EARLY COMPLETION OF ENROLLMENT FOR ISPASM, A PHASE 1/2A
    MEDICURE ANNOUNCES EARLY COMPLETION OF ENROLLMENT FOR ISPASM, A PHASE 1/2A

    https://www.medicure.com/news_details.php?id=122647

    MEDICURE
    28 Jan 2021
    Share Share
    Medicure Announces Early Completion of Enrollment for Ispasm
    Medicure Announces Early Completion of Enrollment for Ispasm

    https://www.prnewswire.com/news-releases/medicure-announces-early-completion-of-enrollment-for-ispasm-a-phase-12a-exploratory-clinical-trial-of-aggrastat-tirofiban-hydrochloride-injection-vs-placebo-for-induced-suppression-of-platelets-activity-in-aneurysmal-subara-301216718.html

    PRNEWSWIRE
    28 Jan 2021
    Share Share
    Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications
    Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications

    https://www.prnewswire.com/news-releases/medicure-announces-aggrastat-shows-promise-in-treating-thrombotic-complications-due-to-covid-19-in-early-clinical-reports-301117225.html

    PRNEWSWIRE
    24 Aug 2020
    Share Share
    Correvio partners with Teson for commercializing cardiac drug in China
    Correvio partners with Teson for commercializing cardiac drug in China

    https://www.biospectrumasia.com/news/25/15578/correvio-partners-with-teson-for-commercializing-cardiac-drug-in-china.html

    BIOSPECTRUMASIA
    11 Mar 2020
    Share Share
    Medicure Files Patent Infringement Action
    Medicure Files Patent Infringement Action

    https://www.prnewswire.com/news-releases/medicure-files-patent-infringement-action-300970393.html

    PR NEWSWIRE
    05 Dec 2019
    Share Share
    FDA Confirms Paragraph IV Patent Challenge ofAggrastat 20913(Tirofiban) Hydrochloride Injection 12.5 mg/250 Ml & 5 mg/100 mL
    FDA Confirms Paragraph IV Patent Challenge ofAggrastat 20913(Tirofiban) Hydrochloride Injection 12.5 mg/250 Ml & 5 mg/100 mL

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-ofaggrastat-20913tirofiban-hydrochloride-injection-125-mg250-ml-5-mg100-ml-1570770363.pdf

    FDA
    11 Oct 2019
    Share Share
    Medicure Files Patent Infringement Action
    Medicure Files Patent Infringement Action

    https://www.prnewswire.com/news-releases/medicure-files-patent-infringement-action-300752397.html

    PR NEWSWIRE
    16 Nov 2018
    Share Share
    Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome
    Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome

    https://www.prnewswire.com/news-releases/cipher-pharmaceuticals-and-cardiome-pharma-announce-strategic-transaction-for-canadian-business-portfolio-of-cardiome-677363803.html

    PR NEWSWIRE
    15 Apr 2018
    Share Share
    Medicure Acquires Exclusive License to Sell & Market Branded Cardio Drug U.S.
    Medicure Acquires Exclusive License to Sell & Market Branded Cardio Drug U.S.

    https://www.prnewswire.com/news-releases/medicure-acquires-exclusive-license-to-sell-and-market-branded-cardiovascular-drug-in-the-us-664158843.html

    PR NEWSWIRE
    14 Dec 2017
    Share Share
    Medicure Announces Filing of ANDA in Collaboration with Apicore
    Medicure Announces Filing of ANDA in Collaboration with Apicore

    http://www.prnewswire.com/news-releases/medicure-announces-filing-of-anda-in-collaboration-with-apicore-606312866.html

    PR NEWSWIRE
    14 Dec 2016
    Share Share
    Medicure Announces Filing of sNDA for New AGGRASTAT® Indication
    Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

    http://www.prnewswire.com/news-releases/medicure-announces-filing-of-snda-for-new-aggrastat-indication-526343471.html

    PR NEWS WIRE
    10 Sep 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search